Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-20-043430

Director acquired 100,503 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

DIGIANDOMENICO ANTHONY · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-07-21 Option exercise : show line 1 in the form +100,503 $0.87 $87,438 382,012 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-07-21 Option exercise : show line 2 in the form Warrants −100,503 0 D
Loading xslF345X03/doc4.xml…